Influence of drugs on arteriovenous vascular access dysfunction

Area of Science:

• Nephrology
• Vascular Surgery
• Interventional Radiology

Background:

• Vascular access dysfunction, specifically venous stenosis, is a primary cause of morbidity and mortality in patients undergoing dialysis.
• Dysfunction occurs at the anastomosis site in arteriovenous fistulas and synthetic grafts.
• Existing therapeutic options for vascular access dysfunction are limited.

Purpose of the Study:

• To review current systemic, endovascular, and perivascular therapies for vascular access dysfunction.
• To highlight the limitations of existing treatments.
• To discuss promising areas of ongoing research for novel interventions.

Main Methods:

• Review of major studies evaluating systemic therapies.
• Review of major studies evaluating endovascular therapies.
• Review of major studies evaluating perivascular therapies.

Main Results:

• Limited efficacy of current systemic therapies for vascular access dysfunction.
• Endovascular and perivascular approaches show potential but face challenges.
• Ongoing research is exploring innovative strategies.

Conclusions:

• There is a critical need for more effective therapies to manage vascular access dysfunction.
• Novel research in systemic, endovascular, and perivascular routes offers hope for improved patient outcomes.
• Further investigation into innovative treatments is warranted.